Vaccination Timing for Splenectomy Patients

Introduction to Vaccination Guidelines

• The American College of Physicians and the Centers for Disease Control and Prevention recommend that all three vaccines (pneumococcal, Haemophilus influenzae type b, and meningococcal) should be administered at least 2 weeks before elective splenectomy or at least 2 weeks after emergency splenectomy in adult patients, with a strength of evidence level of high 1, 2

Rationale for Timing

• Administering vaccines at least 2 weeks before elective splenectomy allows for optimal antibody response and provides protection before the patient becomes functionally asplenic, with a moderate level of evidence 1
• The 2-week pre-surgery timing is particularly important for pneumococcal polysaccharide vaccine (PPSV23), as this timing results in higher antibody concentrations compared to vaccination at shorter intervals before or after surgery, with a high level of evidence 1

Specific Vaccine Recommendations

• For pneumococcal vaccine-naïve patients, PCV13 (or newer PCV15/PCV20) should be administered first, followed by PPSV23 at least 8 weeks later, as recommended by the National Comprehensive Cancer Network, with a high level of evidence 1, 3
• A second dose of PPSV23 should be administered 5 years after the first dose, with a moderate level of evidence 1
• One dose of Hib vaccine is recommended for unvaccinated asplenic adults, with a high level of evidence 1, 2
• Both quadrivalent meningococcal conjugate vaccine (MenACWY) and meningococcal serogroup B vaccine are recommended for asplenic patients, with a high level of evidence 3, 4
• Revaccination with MenACWY is recommended every 5 years, with a moderate level of evidence 1, 3

Common Pitfalls and Considerations

• If vaccination cannot be completed at least 2 weeks before surgery, it should still be administered as soon as possible after the patient's condition stabilizes, with a moderate level of evidence 1, 2
• Patients who have received rituximab in the previous 6 months may have suboptimal response to vaccines, and vaccination should be reassessed once B-cell recovery has occurred, with a high level of evidence 5
• Asplenic patients are at lifelong risk for overwhelming infection, with mortality rates of 30-70%, making proper vaccination timing critical, with a high level of evidence 6

Additional Preventive Measures

• Consider antibiotic prophylaxis (typically phenoxymethylpenicillin) for at least 2 years post-splenectomy, with a moderate level of evidence 5
• Educate patients about their increased infection risk and the need to seek immediate medical attention for fevers over 101°F (38°C), with a high level of evidence 5

Post-Splenectomy Infection Prevention

Vaccination Recommendations

• Reimmunization with PPSV23 is recommended every 5-10 years for asplenic patients, as the 23-valent polysaccharide vaccine is more than 90% effective in healthy adults under age 55 7
• The risk of overwhelming post-splenectomy infection (OPSI) is lifelong and clinically significant, with cases reported more than 20 years after splenectomy, and Streptococcus pneumoniae accounts for approximately 50% of OPSI cases 7
• Children under 2 years have inherently reduced antibody response and should be reimmunized after 2 years 7
• Reimmunization every 5-10 years is essential for maintained protection, especially for vaccines like PPSV23 and MenACWY 7

Preventive Measures

• Lifelong prophylactic antibiotics should be offered to all patients, especially in the first two years post-splenectomy, with phenoxymethylpenicillin as the standard prophylactic agent 7
• Patients should keep emergency standby antibiotics (amoxicillin) at home for immediate use at the first sign of fever, malaise, or chills 7
• Provide written information about lifelong infection risk, and primary care providers must be formally notified of the patient's asplenic status to ensure appropriate ongoing care 7
• After dog or animal bites, asplenic patients require a 5-day course of co-amoxiclav due to susceptibility to Capnocytophaga canimorsus 7

Vaccination Guidelines for Asplenic Patients

Introduction to Vaccination Requirements

• The American College of Physicians recommends that patients undergoing splenectomy receive vaccinations against pneumococcal, meningococcal, Haemophilus influenzae type b, and annual influenza, with a strength of evidence level of high, to prevent overwhelming post-splenectomy infection (OPSI) 8

Optimal Timing for Vaccination

• The Centers for Disease Control and Prevention (CDC) suggests administering all vaccines at least 2 weeks before elective surgery to ensure optimal antibody response, with a moderate level of evidence, and up to 4-6 weeks before surgery if possible 8
• The CDC also recommends vaccinating at least 2 weeks post-operatively once the patient stabilizes after emergency splenectomy, with a low level of evidence 8

Special Populations and Vaccination Considerations

• The Infectious Diseases Society of America (IDSA) notes that patients who received rituximab in the previous 6 months may have suboptimal vaccine response, with a high level of evidence, and vaccination should be reassessed once B-cell recovery has occurred 8
• The IDSA also recommends that patients with functional hyposplenism require identical preventive measures as those with surgical splenectomy, with a moderate level of evidence 8

Additional Preventive Measures

• The American College of Physicians recommends offering lifelong prophylactic antibiotics to all patients, with highest priority in the first 2 years post-splenectomy, with a high level of evidence, and providing emergency standby antibiotics (amoxicillin) for home use at first sign of fever, malaise, or chills 8
• The CDC suggests issuing Medic-Alert disc and post-splenectomy card indicating asplenic status, with a low level of evidence, and educating patients about lifelong infection risk and the need for emergency department evaluation with fever 8

Vaccination Guidelines for Post-Splenectomy Patients

Core Vaccination Requirements

• The National Comprehensive Cancer Network recommends administering PCV20 (preferred) or PCV15 as the initial pneumococcal vaccine for post-splenectomy patients 9
• For patients previously vaccinated with PCV13 only, the National Comprehensive Cancer Network suggests giving PCV20 at least 1 year later 9
• The National Comprehensive Cancer Network advises revaccinating with PPSV23 every 5 years if that vaccine was part of the series 9
• Administer both MenACWY and MenB vaccines, with MenACWY given as 2 doses 8 weeks apart and MenB given as either a 2-dose or 3-dose series depending on formulation, as recommended by the National Comprehensive Cancer Network 9, 10
• Revaccinate with MenACWY every 5 years for life and with MenB every 2-3 years if risk remains, as suggested by the National Comprehensive Cancer Network 9, 10
• The National Comprehensive Cancer Network recommends administering 1 single dose of Haemophilus influenzae type b (Hib) vaccine for unvaccinated adults 9, 10
• All post-splenectomy patients should receive annual inactivated or recombinant influenza vaccine, according to the National Comprehensive Cancer Network 10

Optimal Vaccination Timing

• Administer all vaccines at least 2 weeks before elective surgery, as recommended by the National Comprehensive Cancer Network and Clinical Infectious Diseases 9, 11
• Wait at least 14 days post-operatively before vaccinating in cases of emergency/trauma splenectomy, as suggested by Clinical Infectious Diseases 11

Critical Clinical Pitfalls to Avoid

• Do not forget lifelong revaccination, as protection wanes and infection risk persists for life, requiring MenACWY boosters every 5 years and MenB boosters every 2-3 years, according to the National Comprehensive Cancer Network 9, 10